Board Member Voting
Today MACES members voted on new Board members.
i.e. President – Publications Officer – Education Officer .. More Info to come….
Date: January 21, 2010
RSTI Pacs & Dicom
RSTI provided another free class to MACES members.
The class entailed an entry level introduction to PACS, including the components that make up a filmless imaging system, strategies for planning, implementing and managing the PACS system. The DICOM portion of the class covered the history of DICOM, terminology, role of TCP/IP in DICOM, communication requirements, DICOM files, SCU/SCP roles, transfer syntax, DICOM connectivity, DICOM conformance statements and DICOM software troubleshooting and validation tools.
Date: November 24, 2009
RSIT Basic Imaging
RSTI (Radiological Service Training Institute) taught a one day class on the basics of medical imaging.
For the past 20 years, RSTI has been providing the finest quality in diagnostic imaging training. With a selection of over 30 courses each year, RSTI has trained over 10,000 service professionals from over 30 different countries in radiology, mammography, CT, ultrasound, networking, PACS, and DICOM.
Date: November 23, 2009
Troubleshooting and Repair of Flat Panel Displays
Today Southwestern Biomedical Electronics provided a in-depth training course on how to troubleshoot and repair flat panel displays.
Date: November 12, 2009
BREAKING NEWS!
FDA Clears Noninvasive, Radiation-Free Lung Imaging System
In partnership with Deep Breeze Ltd, Or-Akiva, Israel, GE Healthcare announced FDA 510(k) marketing clearance for the VRIxv, a noninvasive, radiation-free lung imaging system.
“GE Healthcare is helping to facilitate the next era in patient care by providing to the clinical community not only a wide range of ventilation solutions, but also advanced respiratory monitoring tools—such as the VRIxv, which provides a clinician with a window into what is happening inside the lungs in real time,” said Pam Hall, general manager for the critical care segment of the respiratory and sleep business at GE Healthcare. “Our goal is to help clinicians efficiently monitor their patients’ respiratory conditions and help clinicians tailor therapy to improve the outlook for every respiratory patient.”
GE Healthcare and Deep Breeze Ltd have designed the VRIxv to display comprehensive information during the respiratory process on ventilated patients. Employing acoustic sensors that make contact with the patients’ back while lying in bed, the VRIxv records lung sounds. Sophisticated software converts the signals into dynamic images of the lungs with regional distribution maps, numerical representation, and breathing graphs. Each recording samples 20 seconds of lung sounds, typically covering several breath cycles. Monitoring capabilities are enhanced by synchronization of the VRIxv image and vibration energy graph, with the pressure and flow waveforms sampled from the ventilator, which helps to assess the recorded image quickly and objectively.
“The availability of the VRIxv device in the US will allow the critical care community to effectively record and monitor the overall and regional distribution of lung sounds during the respiratory process,” said R. Phillip Dellinger, MD, professor of medicine at Robert Wood Johnson Medical School and director of the critical care division at Cooper University Hospital. “The VRIxv provides the physician with measurements that reveal changes in lung sounds, including changes due to therapeutic treatment, changes due to ventilator settings, or changes due to the clinical conditions in mechanically ventilated patients.”
“The FDA clearance of VRIxv advances our efforts to create a new clinical paradigm in which our VRI [vibration response imaging] technology will be the standard application in a broad line of clinical applications, such as monitoring the impact of ventilator settings or managing risk associated with mechanically ventilated patients.” said David Barton, president, Deep Breeze USA.
FDA Clears Noninvasive, Radiation-Free Lung Imaging System
In partnership with Deep Breeze Ltd, Or-Akiva, Israel, GE Healthcare announced FDA 510(k) marketing clearance for the VRIxv, a noninvasive, radiation-free lung imaging system.
“GE Healthcare is helping to facilitate the next era in patient care by providing to the clinical community not only a wide range of ventilation solutions, but also advanced respiratory monitoring tools—such as the VRIxv, which provides a clinician with a window into what is happening inside the lungs in real time,” said Pam Hall, general manager for the critical care segment of the respiratory and sleep business at GE Healthcare. “Our goal is to help clinicians efficiently monitor their patients’ respiratory conditions and help clinicians tailor therapy to improve the outlook for every respiratory patient.”
GE Healthcare and Deep Breeze Ltd have designed the VRIxv to display comprehensive information during the respiratory process on ventilated patients. Employing acoustic sensors that make contact with the patients’ back while lying in bed, the VRIxv records lung sounds. Sophisticated software converts the signals into dynamic images of the lungs with regional distribution maps, numerical representation, and breathing graphs. Each recording samples 20 seconds of lung sounds, typically covering several breath cycles. Monitoring capabilities are enhanced by synchronization of the VRIxv image and vibration energy graph, with the pressure and flow waveforms sampled from the ventilator, which helps to assess the recorded image quickly and objectively.
“The availability of the VRIxv device in the US will allow the critical care community to effectively record and monitor the overall and regional distribution of lung sounds during the respiratory process,” said R. Phillip Dellinger, MD, professor of medicine at Robert Wood Johnson Medical School and director of the critical care division at Cooper University Hospital. “The VRIxv provides the physician with measurements that reveal changes in lung sounds, including changes due to therapeutic treatment, changes due to ventilator settings, or changes due to the clinical conditions in mechanically ventilated patients.”
“The FDA clearance of VRIxv advances our efforts to create a new clinical paradigm in which our VRI [vibration response imaging] technology will be the standard application in a broad line of clinical applications, such as monitoring the impact of ventilator settings or managing risk associated with mechanically ventilated patients.” said David Barton, president, Deep Breeze USA.
Date: November 8, 2009